HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers

Current ADC landscape (ID 2)

Lecture Time
17:05 - 17:25
Session Name
HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers
Room
Berlin Hall
Date
Thu, 11.05.2023
Time
16:45 - 18:15
Speakers
  • Veronique C. Dieras (Rennes, France)
Authors
  • Veronique C. Dieras (Rennes, France)
  • Hope S. Rugo (San Francisco, CA, United States of America)